Multimodality treatment of intrahepatic cholangiocarcinoma: A review.

Authors

• Kerri A Simo
• Laura E Halpin
• Nicole M McBrier
• Jacob A Hessey, OhioHealth
• Erin Baker
• Samuel Ross
• Ryan Z Swan
• David A Iannitti
• John B Martinie

Document Type

Article

Publication Title

Journal of surgical oncology

Abstract

Intrahepatic cholangiocarcinoma (iCCA) is the second most common primary hepatic cancer in the United States. Currently, curative treatment involves aggressive surgery. Chemotherapy and radiation treatments have been used for unresectable tumors with some success. Optimizing the use of current and developing novel multimodality treatment for iCCA is essential to improving outcomes.

First Page

62

Last Page

83

DOI

10.1002/jso.24093

Publication Date

1-1-2016

Recommended Citation

Simo KA, Halpin LE, McBrier NM, Hessey JA, Baker E, Ross S, Swan RZ, Iannitti DA, Martinie JB. Multimodality treatment of intrahepatic cholangiocarcinoma: A review. J Surg Oncol. 2016 Jan;113(1):62-83. doi: 10.1002/jso.24093. PMID: 26797780.